Market Scenario, Oligonucleotide Synthesis Market is expected to register a CAGR of 13.19% during the forecast period of 2019 to 2025. , Oligonucleotides are little fragments of nucleic acids that are produced through enzymatic chemistry and genetic engineering. Oligonucleotides are primarily used in laboratories for diagnostics, academic and industrial, and therapeutic applications. Oligonucleotide synthesis occurs either commercially to deliver services for various end-users or individually through DNA synthesizers for self-consumption. Currently, successive enhancements in oligonucleotide synthesis, magnification, and automation have entirely revolutionized biological research. It is also feasible to do the customizations and get the essential sequence online easily and at the required time. These services fluctuate greatly by the cost of per base pair, error rates, lengths, and throughput, among others., Segmentation, The Global Oligonucleotide Synthesis Market has been segmented based on Product, Type, Application, End-User, and Region., The Global Oligonucleotide Synthesis Market, based on product, has been bifurcated into oligonucleotide, reagents, and equipment., Based on type, the market is further segmented into custom oligos, predesigned oligos. The global oligonucleotide synthesis market, based on application, has been segmented into therapeutic applications, diagnostics, research, and others. On the basis of end-user, the market has been bifurcated into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and others., The global oligonucleotide synthesis market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The oligonucleotide synthesis market in the Americas has further been branched into North America and Latin America; the North American market has been divided into the US and Canada. The European oligonucleotide synthesis market has been sub-divided into Western Europe and Eastern Europe. The market i

Market Scenario

Oligonucleotide Synthesis Market is expected to register a CAGR of 13.19% during the forecast period of 2019 to 2025.

Oligonucleotides are little fragments of nucleic acids that are produced through enzymatic chemistry and genetic engineering. Oligonucleotides are primarily used in laboratories for diagnostics, academic and industrial, and therapeutic applications. Oligonucleotide synthesis occurs either commercially to deliver services for various end-users or individually through DNA synthesizers for self-consumption. Currently, successive enhancements in oligonucleotide synthesis, magnification, and automation have entirely revolutionized biological research. It is also feasible to do the customizations and get the essential sequence online easily and at the required time. These services fluctuate greatly by the cost of per base pair, error rates, lengths, and throughput, among others.

Segmentation

The Global Oligonucleotide Synthesis Market has been segmented based on Product, Type, Application, End-User, and Region.

The Global Oligonucleotide Synthesis Market, based on product, has been bifurcated into oligonucleotide, reagents, and equipment.

Based on type, the market is further segmented into custom oligos, predesigned oligos. The global oligonucleotide synthesis market, based on application, has been segmented into therapeutic applications, diagnostics, research, and others. On the basis of end-user, the market has been bifurcated into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and others.

The global oligonucleotide synthesis market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The oligonucleotide synthesis market in the Americas has further been branched into North America and Latin America; the North American market has been divided into the US and Canada. The European oligonucleotide synthesis market has been sub-divided into Western Europe and Eastern Europe. The market in Western Europe has further been divided into France, the UK, Germany, Italy, Spain, and the rest of Western Europe. The oligonucleotide synthesis market in Asia-Pacific has been segmented into India, South Korea, Japan, China, Australia, and the rest of Asia-Pacific. The oligonucleotide synthesis market in the Middle East & Africa has been divided into the Middle East and Africa.

Key Players

The Key Players in the Global Oligonucleotide Synthesis Market are Thermo Fisher Scientific, Inc., Adtbio, Merck - Co., Inc., Bio-Synthesis Inc., Eurofins Genomics, GE Healthcare, Horizon Discovery Ltd, Agilent Technologies, Genscript, Kaneka Eurogentec SA, Nitto Denko Avecia, Integrated DNA Technologies, Inc., BioAutomation, LGC Biosearch Technologies, Sarepta therapeutics, Agilent Technologies and others.

Regional Market Summary

Global Oligonucleotide Synthesis Market Share by Region, 2018 (%)



Source: World Health Organization (WHO)

The market in the Americas is expected to dominate the global oligonucleotide synthesis market due to the existence of better health care infrastructure and increasing usage of oligonucleotides by pharmaceutical companies of the region and many strategic collaborations among the players in the market. For instance, CordenPharma International, in June 2017, signed a strategic collaboration with GE Healthcare for the development of an end-to-end oligonucleotide-based drug discovery solution.

The market in Europe registers considerable growth, which can be attributed to the presence of a well-established healthcare system and increasing initiatives by government bodies for the development of novel treatment options and is estimated to provide the market with high growth potential. The market in Asia-Pacific is projected to have a steady growth rate during the forecast period owing to the increasing patient awareness and increasing government initiatives for healthcare reforms. The market in the Middle East & Africa is projected to account for the least share of the global market due to low disposable income in the region.

Global Oligonucleotide Synthesis Market, by Product



Oligonucleotide



Column-based oligos

Array-based oligos







Reagents



Equipment



Global Oligonucleotide Synthesis Market, by Type



Custom Oligos



Predesigned Oligos



Global Oligonucleotide Synthesis Market, by Application



Therapeutic Applications



Diagnostics



RNAi

Nucleic Acid Aptamers

DNA/Antisense Oligonucleotides

Immunotherapy







Research



PCR

QPCR/RTQPCR

Sequencing

Gene Synthesis







Others



Global Oligonucleotide Synthesis Market, by End User



Hospitals



Specialty Clinics



Research Institutes



Diagnostic Centers



Others



Global Oligonucleotide Synthesis Market, by Region



Americas



North America



US

Canada





Latin America











Europe



Western Europe



Germany

France

Italy

Spain

UK

Rest of Western Europe





Eastern Europe











Asia-Pacific



Japan

China

India

Australia

South Korea

Rest of Asia-Pacific











Middle East & Africa



Middle East

Africa









Intended Audience



Research and development (R&D) companies



Medical device companies



Government research institutes



Academic institutes and universities



Venture capitalists



Frequently Asked Questions (FAQ) :